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ABSTRACT

Endothelial cell motility is central to several biological processes including angiogenesis during wound healing, reendothelialization of vessel walls after
damage and neovascularization of tumors. However, control mechanisms that stimulate and inhibit cell movement are not known. Our objective is to
understand the signals that initiate movement of endothelial cells. To examine these questions, we used an in vitro wound model of quiescent pulmonary artery
endothelial cell monolayers which were stimulated to move by mechanical injury. Ca2+ signaling at the time of wounding produces long lasting effects on cell
movement. We investigated whether new gene transcription after wounding might also stimulate endothelial cell movement. Specifically, we examined
transcriptional activation of vascular endothelial cell growth factor (VEGF) after injury. While many studies have reported that tumor and epithelial cells
produce VEGF, there is conflicting evidence for VEGF synthesis by endothelial cells. We found that RNA transcripts for 121 and 165 amino acids VEGF
isoforms were expressed in quiescent endothelial cells. These transcripts were also produced by ovarian cancer cells which induce angiogenesis in vivo.
Surprisingly, after wounding, additional RNA transcripts encoding the 189 amino acid VEGF isoform were induced. VEGF might self-stimulate endothelial
cells since exogenous, recombinant VEGF accelerated cell motility as much as basic fibroblast growth factor. Our data suggest that expression of the 189 amino
acid VEGF isoform is upregulated in response to extravascular signals such as mechanical wounding. VEGF might act in an autocrine or paracrine manner to
stimulate movement after wounding.

Cell motility is a critical aspect of successful wound healing,
yet its regulation is not well understood. To facilitate studies of
motile cells, we focused on control of motility during activation
of quiescent cells in vitro. Initiation of motility is of special
interest since essential regulatory signaling pathways are likely to
be revealed during the transition to a motile state. To model
initiation of cell movement, we examined confluent endothelial
cell monolayers. Movement was initiated in cultured monolayers
upon release from contact inhibition by mechanical scraping.
Release from contact inhibition, while necessary, was not
sufficient to initiate cell movement. We found that stimulatory
wound factors derived from injured cells were required for
movement in addition to removal of inhibitory cell-to-cell
contacts 1. The wound factors include soluble ligands that
mobilize intracellular free Ca 2+ ([Ca2+]i). 1 Briefly increasing or
decreasing Ca 2+ increased or decreased the rate of motility for
hours, suggesting that transient signaling events had long term
effects 2. These results suggest that motility is actively initiated by
intracellular messengers. Although Ca2+ is important to motility,
the mechanism of regulating motility by Ca2+ remains unknown.
We also found th at inducing motility of quiescent endothelial
cells required new gene expression since actinomycin D
treatment within the first hour postwounding prevented
subsequent cell movement. Interestingly, maintenance of cell
motility did not require mRNA synthesis since inhibition of gene
expression one hour after wounding had no effect on wound
closure (Sammak et al., unpublished observations). Therefore, we
propose that transcripts encoding protein products essential for
motility are lacking in quiescent cells and are manufactured
within the first hour after wounding.
Our long term goal is to determine whether endothelial cell
motility is initiated by intracellular messenger-stimulated gene
expression. One candidate that could affect motility is vascular
endothelial cell growth factor (VEGF). VEGF expression has

Address for correspondence:

been shown to be stimulated by Ca 2+ 3•4 and stimulation of
motility by Ca2+ might be mediated, in part, by synthesis of
VEGF. VEGF is known to have a specific function in vascular
development. 5-7 Deletion of a single allele is lethal in utero
because of deficient blood vessel ingrowth during implantation. 8
Control of VEGF by [Ca2+]i might mediate, in part, endothelial
cell motility during angiogenesis and vasculogenesis. We report
here that mRNA for one isoform of VEGF is selectively
synthesized in response to wounding and that a pulse of
exogenous VEGF stimulates motility for hours.
MATERIALS AND METHODS

Calf pulmonary artery endothelial cells (CPAE; line CCL
209, ATCC, Rockville, MD), were cultured in Dulbecco's
modified Eagle' s medium (DMEM, Gibco Life Sciences, Grand
Island, NY) supplemented with 5 mg/mL penicillin, 5 mg/mL
streptomycin and I 0% fetal bovine serum, (FBS, Hyclone
Laboratories, Logan, UT). Transformed OVCAR-3 epithelial
ovarian carcinoma cells (NCI Frederick Facility, Frederick, MD)
were cultured in RPMI 1640 with 15% FBS and antibiotics. Cells
were grown to confluence (2 - 3 days). For motility experiments,
cells were starved (serum free medium) for 2 days in DMEM
containing 0.1 % bovine serum albumin (Sigma, St. Louis, MO)
with penicillin and streptomycin to reduce effects of exogenous
growth factors on wound response.
To measure gene expression induced by wounding, we
collected cells stimulated by nearby wounding, but not
themselves fatally damaged. A confluent, starved 100 mm plate
of cells was wounded with a comb designed so that all cells that
remained intact were stimulated by nearby wounds. Dead cells
were scraped off and were washed away before collecting RNA
from surviving cells. Total RNA was isolated from endothelial
cell monolayers one hour after mechanical injury using Trizol per
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manufacturer's instructions (Gibco Life Sciences, Grand Island,
NY). Reverse transcriptase-polymerase chain reaction (RT-PCR)
was done using oligonucleotide primers (5' GGGCTCGAGCA
CCCATGGCAGAAGGA 3' and 5' GGGGGATCCCTGCCCG
GCTCACCGCCTCGG 3') specific for VEGF as previously
described. 9 The flt-1 specific primers were (5'CGCGGTC
TTGCCTT ACGCGCT 3' and 5'CCATTTATGGGCTGCTTCC
CCCCTGCA3 ') as previously described5
To measure motility during healing, wounds were made by
scratching monolayers with an 18-g needle (8 J.lm diameter),
which removed a 4 to 6 cell-wide swath (about 100- 200 J.lm) .
Hank's balanced salt solution (HBS S), with or without
recombinant VEGF (165 ami no acid isoform), 10 was added 0.5
minutes before through 4.5 minutes after wounding. After
wounding, dishes were drained, washed with HB SS, refilled with
serum-free DMEM, and reincubated. Dead cells, disti nguishable
in phase contrast microscopy by their lucidity, were limited to the
first row of cells at the wound edge. 1 Most dead cells rounded up
and floated away before the first measurement at I hour. At one,
two and three hours postwounding, wound area was measured
using a Nikon TMS microscope equipped with a lOX objective
and a Cohu CCD camera that provided direct video input into a
Macintosh video-capable computer. Areas were calculated with
the public domain program, NIH Image (available by FfP from
zippy.nimh.nih.gov). Distances were calibrated with a stage
micrometer (Fisher Scientific, Pittsburgh, PA). From these
measurements, changes in wound width between one and three
hours postwounding were calculated. Wound closure was
proportional to the net rate of cell movement and spreading,
averaged over 100 cells. Cell proliferation did not occur during
the initial three hours postwounding.
R ESULTS

We determined whether VEGF was expressed in CPAE cells
using RT-PCR, with oligonucleotide primers specific to VEGF
and its receptor, flt-1 . RNAs encoding VEGF were detected in
total RNA isolated from CPAE endothelial cells before wounding
and at one hour after wounding. As a control, total RNA from
transformed OVCAR-3 epithelial ovarian carcinoma cells was
also analyzed. Lanes A and B show that nonwounded CPAE cells
ex press mRNA for two isoforms of VEGF (121 and 165 amino
acids) and the flt-1 receptor, respectively (fig 1). Since CPAE
cells express flt-1, it is likely that these cells are responsive to
VEGF. Transformed OVCAR-3 cells also express isoforms for
these two VEGF peptides (Lane C), but not the receptor (Lane D),
and are not responsive to VEGF (not shown) . Surprisingly, RTPCR using RNA isolated from CPAE cells one hour after
wounding demonstrated mRNA encoding the 189 amino acid
isoform of VEGF in addition to transcripts for the 12 1 and 165
amino acid isoforms (Lane E) .
VEGF has been reported to stimulate angiogenesis in vivo
and proliferation of CPAE cells in vitro. 10 However, effects of
VEGF on cell motility have not been well described. We applied
VEGF for 5 minutes during mechanical wounding and measured
the width of wounds at I and 3 hours post wounding. The rate of
wound closure during this period was stimulated by VEGF in a
concentration-dependent manner (Table 1). The average speed at
low doses (29. 1 J.!mlhr at 0.01 - I ng/mL) differed from that at
high concentrations (35.2 J.!mlhr at 10- 100 ng/mL; p < 0.05). At
higher concentrations, cells rounded while moving (I 11g/mL).
Note that VEGF was applied for only 5 minutes during wounding
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and that motility was measured for hours. VEGF increased
wound closure rates as much as I 0 ng/mL bFGF (increased
movement by about 50%; from 23 to 35 J.!mlhr) and stimulated
movement more than insulin (applied continuously stimulated
movement by about 20%; from 20 to 26 J.!mlhr) (Table 1).
DISCUSSION

Whether or not VEGF is synthesized by endothelial cells is
controversial. Most reports suggest that VEGF is synthesized by
epithelial but not endothelial cells. 1l-J3 The target for VEGF
action is endothelial not epithelial tissues since VEGF receptors
are expressed by endothelium. 14 Therefore, most studies support
a paracrine function of epithelial-derived VEGF acting on
vascular endothelium. In contrast, a few studies support an
autocrine function of endothelial-derived VEGF. 15, !6 The
variability amo ng reports abo ut VEGF production by
endothelium might be accounted for by the difference between
normal and activated endothelium. VEGF might not be present in
nonproliferative vascular endothelium but might be induced by
stress or other stimuli.
We have found that RNA transcripts for one VEGF isoform
was specifically expressed in endothelial cells only after
mechanical injury. Serum starved endothelial cells produced
transcripts for the 165 and 121 amino acid isoforms of VEGF
peptide and for the VEGF receptor, flt-1 (fig I). Upon wounding,
expression of transcripts encoding the 189 amino acid VEGF
isoform also were induced. It is not known whether these
isoforms have different effects on motility. Exogenous
recombinant VEGF ( 165 amino acid isoform) stimulated
endothelial cell motility in a concentration-dependent manner as
much as bFGF and more than insulin (Table 1). This suggests that
wound-derived signals might set up an autocrine control of cell
movement by induction of VEGF expression. An autocrine role
of VEGF for initiation of motility might not be found in quiescent
endothelial cells under other conditions.
In other studies, we found that immediate-early genes, c-fos
and c-jun, are induced minutes after wounding, and that Ca2+
differentially induces c-fos, but not c-jun. 17 These factors
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Figure I. RT-PCR detection of VEGF and its receptor, flt-1, in
endothelial cell s. RT-PCR, using primers for VEGF and flt-1 was
performed on total RNA isolated from CPAE endothelial cells and
trans formed OVCAR-3 ovarian carcinoma cells. Lane A shows
transcripts for two VEGF isoforms (121 and 165 amino acids; aa) from
nonwounded CPAE cells. Lane B shows transcripts for flt-1 receptor
from these same cells. Transcripts for the two VEGF isoforms (Lane C),
but not the receptor (Lane D), were fo und in transformed OVCAR-3
cells. One hour after wounding, CP AE cells contained transcripts for
three VEGF isoforms (189, 121 and 165 aa; Lane E).

j ournal of the Minnesota Academy of Science

Induction of VEGF by Wounding

Table 1: Stimulation of wound closure (flmlhr) by VEGF, bFGF, and Insulin
Growth Factor 1

VEGF

concentration
Control 2

0.01

0.1

10

100 ng/mL

23.1 ± 1.4

Treated3

27.4

31.0

29.2

29.2 ± 1.8*

bFGF

Insulin

10 ng/mL

10 11M

23.0 ± 1.7

20.0 ± 2.6

35.0 ± 6.6*

26.0 ± 3.4*

34.8

35.8

35.2 ± l .O* t

1 VEGF applied for 5 minutes , bFGF for 2 minutes , insulin continuously.
2 Data are means ± I sd; n = 4
3 VEGF dose-response series are data representative of two replicates (two wounds each, 60 cells/wound).
p < 0 .05 vs control ; t p < 0 .05 vs 0 .01 - 1 ng/mL VEGF

*

dimerize to form the activator protein-! (AP-I) complex involved
in VEGF expression . 18 VEGF expression also can be induced by
Ca 2+, 3.4 protein kinase C and cAMP. 4 · 14 Thus, wound-induced
signals such as [Ca 2+]i, c-fos and c-jun might stimulate VEGF
synthesis. Yet, in hypoxia, VEGF synthesis also is induced
independent of AP-1. 19 It remains to be determined whether
VEGF induction during wounding is mediated by AP-I factors .
Our working hypothesis is that transient mobilization of
[Ca 2+]i triggers long term stimulation of movement by a
sustained autocrine mechanism. A signaling cascade beginning
with [Ca 2+]i (lasting seconds) might initiate primary genes, such
as c-fos and c-jun (lasting minutes) which, in turn , might activate
the secondary gene VEGF (lasting hours) . Sustained production
of VEGF, then, could maintain cell motility at a rate that was
defined by its level of expression.
How might VEGF stimulate cell movement? The specificity
and potency of VEGF for motility of endothelial cells has been
studied . One effect is to increase expression of urokinase-type
plasminogen activator and av~ 3 integrin which speed movement
and lamella formation . 20 ·21 One hypothesis for effects of
urokinase is competition for plasminogen activator inhibitor
which can slow cell movement by competing with vitronectin for
binding to av~ 3 integrin. 22 Adherence of pulmonary artery
endothelial cell s depends on mobilizing av~ 3 in a [Ca 2+]idependent manner. 2 Thus , VEGF might alter av~ 3 -dependent cell
ad hesion . Investigation of the effects of VEGF on motility, cell
adhesion and lamella formation is needed to resolve these
questions.
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